GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,756.20p
   
  • Change Today:
      36.60p
  • 52 Week High: 1,810.40
  • 52 Week Low: 1,380.40
  • Currency: UK Pounds
  • Shares Issued: 5,084m
  • Volume: 6,252,376
  • Market Cap: 89,286m
  • RiskGrade: 129

GSK Overview

UK-based GSK Plc is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book n/a  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

GSK Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%
31-Dec-18 30,821.00 4,800.00 119.40p 12.5 1.8 +7% 80.00p 5.4%
31-Dec-19 33,754.00 6,221.00 123.90p 14.4 3.6 +4% 80.00p 4.5%
31-Dec-20 34,099.00 6,968.00 115.90p 11.6 n/a -6% 80.00p 6.0%
31-Dec-21 34,114.00 5,442.00 113.20p 14.2 n/a -2% 80.00p 5.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GSK Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 35,973.33 8,416.04 120.92p 14.5 2.1 +7% 52.27p 3.1%
31-Dec-23 37,021.55 9,230.30 129.46p 13.6 1.9 +7% 53.98p 3.2%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

GSK Company Announcements

Director/PDMR Shareholding 24-Jun-2022 15:44 RNS
Director/PDMR Shareholding 16-Jun-2022 10:58 RNS
Positive phase III data for GSK’s RSV OA v... 10-Jun-2022 07:00 RNS

Latest GSK Director Deals

Traded Action Notifier PriceAmountValue
23-Jun-22 Buy Urs Rohner 1,691.00p 610 10,315.10
23-Jun-22 Buy Jesse Goodman 1,697.32p 668 11,338.10
23-Jun-22 Buy Laurie Glimcher 1,697.32p 2,024 34,353.77

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GSK Market Data

Currency UK Pounds
Share Price 1,756.20p
Change Today 36.60p
% Change 2.13 %
52 Week High 1,810.40
52 Week Low 1,380.40
Volume 6,252,376
Shares Issued 5,084m
Market Cap 89,286m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
76.25% above the market average76.25% above the market average76.25% above the market average76.25% above the market average76.25% above the market average
87.30% above the sector average87.30% above the sector average87.30% above the sector average87.30% above the sector average87.30% above the sector average
Income Not Available
Growth
69.68% below the market average69.68% below the market average69.68% below the market average69.68% below the market average69.68% below the market average
90% below the sector average90% below the sector average90% below the sector average90% below the sector average90% below the sector average

What The Brokers Say

Strong Buy 7
Buy 1
Neutral 12
Sell 0
Strong Sell 1
Total 21
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 19-May-22 24-Feb-22
Paid 01-Jul-22 07-Apr-22
Amount 14.00p 23.00p

Trades for 24-Jun-2022

Time Volume / Share Price
16:45 16,734 @ 1,753.00p
16:45 16,734 @ 1,753.00p
16:41 300,000 @ 1,751.76p
16:39 1,000 @ 1,756.20p
16:39 14,000 @ 1,756.20p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page